MedTech News
Editing Parkinson’s disease—discovery of an inflammatory RNA editing enzyme
The research team, led by Professor Minee L. Choi from the Department of Brain and Cognitive Sciences, in collaboration with University College London (UCL) and the Francis Crick Institute, discovered that the RNA-editing enzyme ADAR1 plays an important role in controlling immune responses in astrocytes, glial cells that trigger protective reactions in the brain, and demonstrated that this mechanism is critically involved in the progression of Parkinson’s disease.
FaceHeart Receives FDA Clearance for Contactless Video-Based Respiratory Rate Measurement
FaceHeart Vitals™ is a video-based, contactless vital sign measurement SDK that can be integrated into devices such as smartphones seamlessly, providing heart rate, respiration rate, blood pressure and other vital sign readings in 50 seconds.
Detecting Parkinson’s disease with a simple retinal exam
Could it be possible to diagnose Parkinson’s disease with the help of a simple retinal exam? The idea should be seriously considered, according to a study published in the May issue of Neurobiology of Disease by researchers from Université Laval who discovered that the retina of people with Parkinson’s disease responds differently to light stimuli than that of healthy people.
Novel intranasal vaccine technology shows promise for broad protection against respiratory viruses
In Nature Communications, the laboratory of Professor Jan Terje Andersen and collaborators report on a novel vaccine technology platform, in which the subunit antigen is genetically fused to albumin.
Tiny RNA molecule may hold the key to treating knee osteoarthritis
A discovery by scientists at Henry Ford Health + Michigan State University Health Sciences could pave the way for new breakthroughs in detecting and treating the disease. Their findings were recently published in Nature Communications.
Study of facial bacteria could lead to probiotics that promote healthy skin
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
Edwards wins FDA nod for TAVR in aortic stenosis without symptoms
Edwards Lifesciences (NYSE: EW) announced today that it received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
Intuitive earns expanded FDA nod for da Vinci single port system
Intuitive (NASDAQ: ISRG)+
announced today that it received FDA clearance for a new indication for its da Vinci single port (SP) surgical robot.